<DOC>
	<DOCNO>NCT00529126</DOCNO>
	<brief_summary>Phase 2 study evaluate three dose level SKY0402 compare 75 mg bupivacaine HCl .</brief_summary>
	<brief_title>Phase 2 Dose-Ranging Study SKY0402 Prolonged Postoperative Analgesia Subject Undergoing Hemorrhoidectomy</brief_title>
	<detailed_description>Effective postoperative pain control critical element patient recovery , majority patient may experience significant pain , particularly first day follow surgery . Appropriate postoperative pain management contribute improved healing , faster patient mobilization , shorten hospital stay , reduce healthcare cost .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Male female , 18 year age old Screening Visit . 2 . Applies female subject : Postmenopausal , surgically sterile , willing use acceptable mean contraception least 30 day surgery include follow : hormonal contraceptive ( e.g. , oral , injectable , implantable start least 30 day study drug administration ) , effective doublebarrier method ( e.g. , condom spermicide ) , intrauterine device , lifestyle personal choice abstinence , nonheterosexual lifestyle , strictly monogamous relationship partner vasectomy . 3 . Scheduled undergo 2 3column excisional hemorrhoidectomy general anesthesia use Milligan Morgan Fergusontype technique , include modified approach specialize instrument , LigaSureâ„¢ harmonic scalpel , cumulative incision length minimum 3 cm . 4 . American Society Anesthesiology ( ASA ) Physical Class 13 . 5 . Able willing comply study visit procedure . 6 . Able speak , read , understand language Informed Consent Form ( ICF ) , study questionnaire , instrument use collect subjectreported outcome , order enable accurate appropriate response pain scale require study assessment . 7 . Willing capable provide write informed consent . 1 . Pregnancy , nursing , plan become pregnant study within one month study drug administration . 2 . Use following medication within time specify surgery : Longacting opioid medication within 3 day . Any opioid medication within 24 hour . 3 . Concurrent painful physical condition may require analgesic treatment postoperative period pain surgically relate may confound postoperative assessment ( e.g. , rheumatoid arthritis , chronic neuropathic pain ) . 4 . Singlecolumn hemorrhoidectomy hemorrhoidectomy without internal component . 5 . Body weight less 50 kilogram ( 110 pound ) . 6 . History hypersensitivity idiosyncratic reaction amidetype local anesthetic opioid medication . 7 . Contraindication epinephrine , concurrent administration monoamine oxidase ( MAO ) inhibitor antidepressant amitriptyline imipramine type , condition production exacerbation tachycardia could prove fatal ( e.g. , poorly control thyrotoxicosis severe heart disease ) , pathological condition might aggravate effect epinephrine . 8 . Contraindications paincontrol agent plan postoperative use ( e.g. , acetaminophen [ paracetamol ] , oxycodone , morphine , ketorolac ) . 9 . Administration investigational drug within 30 day 5 elimination halflives investigational drug , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study . 10 . History , suspect , know addiction abuse illicit drug ( ) , prescription medicine ( ) , alcohol within past 2 year . 11 . Uncontrolled anxiety , schizophrenia , psychiatric disorder , opinion Investigator , may interfere study assessment compliance . 12 . Significant medical condition laboratory result , opinion Investigator , indicate increase vulnerability study drug procedure , expose subject unreasonable risk result participate clinical trial , : debilitating disease , acute illness , hypotension , partial complete conduction block , impaired cardiac function , untreated hypertension , advance arteriosclerotic heart disease , cerebral vascular insufficiency , preexist abnormal neurological neuromuscular disease ( e.g. , epilepsy , myasthenia gravis ) , advance liver disease , severe renal impairment , advanced diabetes , comorbid condition associate immunocompromised status , blood dyscrasia , HIV/AIDS , recent chemotherapy . In addition , subject ineligible receive study drug meet follow criterion surgery : 13 . Any clinically significant event condition uncover surgery ( e.g. , excessive bleeding , acute sepsis ) might render subject medically unstable complicate subject 's postoperative course . 14 . A cumulative incision length le 3 cm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hemorrhoidectomy</keyword>
	<keyword>pain</keyword>
	<keyword>Postoperative</keyword>
	<keyword>analgesia</keyword>
</DOC>